Abstract  by unknown
JACC February 1997 ABSTRACTS - Orai 171A
9:00
m7283 HighPreesureInflationinConjunctionwithTiclopidineandAepirinFoliowingCoronaryStent
Placement:ReeultsoftheSTRESSIliTriai
D.L. Fiechman, M.P. Savage, 1.Penn, J. Hirehfeld, M. Nobuyoshi, S. Ellis,
J. Moses, J. Werner, R. Rake, S. Gebhardt, C. Dempsey, D. Rehmann, for
the Sheldon Goldberg for the STRESS Ill Investigators. Jefferson Medical
College, Philadelphia, PA, USA
STRESS Ill is a prospective, multicenter trial to assesa acute and long-term
outcomes of single Palmaz-Sehatz stent placement for new focal lesions
in native corona~ arteries using high pressure inflation in conjunction with
ticlopidine and aspirin. The inclusion criteria are identical to thoee of the
original STRESStrial. Enrollment of 250patienteat 15centerswascompletd
in August 1996 with 6 month angicgraphy to be completed in February 1997.
Baseline patient demographics are closely matched, except for an increased
percentage of women (17% vs 26%, p = 0.06) and higher incidence of
hyperlipidemia (44% vs 61%, p = 0.02) in STRESS Ill patients. Procedural
success wee similar (96.1% VS96.77., p = ns). Compared with STRESS
stent patients, STRESS Ill patients had fewer stent thromboaea (3.4% vs
1.2Y0,p = 0.12) and bleeding and vaSCLdarcomplications (7.3% vs 0.6%,
p = 0.003). Length of hospital stay was redueed from 5.8 days to 1.6 days
(p < 0.0001). Quantitative coronary analysis has been completed on 193
pstienta. Interim resulta revealed smaller baseline referance vessel aize
(3.04 vs 2.63 mm, p < 0.0001), greeter acute gain (1.72 vs 1.66 mm, p
= 0.02), and less residual stenosis (19% vs 9%, p c 0.0001) in STRESS
Ill compared with STRESS. Thus, the use of ticlopidine in conjunction with
high preeeure inflation resulted in improved early clinical and angiographic
outcomes compared with STRESS stent patients. Angiogrephic restenoais
and target lesion revaecularization will be compared to ascertain whether
these superior initial reeults will be translated into long-term benefit.
9:15
m7284 IntravaacuierUltrasoundResuitsfromthe ReducedAnticoagulstionVeinGraftStudy(RAVES)
A. Abizaid, G.S. Mintz, A.D. Pichard, L.F. Satler, K.M. Kent, S.G. Ellia,
M.P.Savage, J. Moses, S.R. Ramee, S.B. King, Ill, J. Griffin, M.B. Leon.
Washington Hospital Center, Washington, DC, USA
RAVES was a multicenter registry designed to test the safety of sole an-
tiplatelet (ASA and ticlopidine) therapy after Palmez-Schatz coronaty stent
implantation followed by high-pressure”adjuncf PTCAin 200 pts withvein graft
lesions. Intravascular ultrasound (IVUS) was performed at the completion of
the procedure not to guide, but to “document” final results. The adequacy of
stent implantation was judged by 3 IVUS parameters: full stent expansion
(minimum stent area ?60% reference lumen area), complete atent-vein graft
apposition, and stent symmetry (minimutimaximum stent diameter >0.7)}.
Resuits were compared to biinded quantitative coronary angiogrephy {QCA:
measurement of reference and minimum lumen diameters (MLD), in mm,
and diameter stenosis}.
Ivus QCA A r P
Reference 3.67* 0.66 3.03 +0.59 0.69 +0.49 0,681 <0.0001
MLD 3.09+0.55 2.S5 + 0.51 0.30+0.50 0.567 <0.0001
Stenosis 15* 11”/& 4 * 14% 10* 15 0.369 <0.0001
In 36%, stent implantation failed to meat 1 of the 3 criteria, most often
a stent area <60Y0 referance lumen area. Importantly, achieving optimal
IVUS etent implantation criteria was not associated with reduced subacute
stent thrombosis (O% overall!) or improved QCA final MLD. Other IVUS
findings inciuded infrequent (9%) stent-edge dissections and a surprisingly
large average plaque burden (41 + 10%) outside tha stented segment.
kVaconclude: Documentary IVUS after high-pressure stenting in vein graft
lesions (1) shows consistently greater lumen dimensions mmpsred with QCA
and (2) suggests that achieving “optimal” IVUS parameters may have little
effect on subacute thrombosis and final lumen diameters.
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]~[ six Monthciinica,andAn~io~raPhic~u~comeAfier
IVUSGuidedStentimplantation
H. Mudre, M. Sunamura, H. Figulla, Y.Almagor, L. Bilodeau, 1.Penn,
A. Colombo, C. Harem, A. Bartorelli, M. Rothman, M. Nobuyoshi,
T. Yamaguchi, V. Voudris, S. Makovski, C. Hausmann, P.de Jaegere. Music
Study hrvestigatora, Rotterdam, The Netherlands
Preliminary date indiostethat systemic anticoagulation csn aafely be omitted
in case of IVUS guided stent implantation. The impact of IVUS guidance on
the long-term clinical and angiographic outcome is less studiad. Therefora,
major cardiac events as well aa changes in stenosis geometry (CAAS Sya-
tem) and restenosis rate (250% diameter stenosis) were aasessed in 161
ptewho received a single Palmaz-Schatz stent because of stable angina and
a de novo corona~ lesion. Pts meeting the IVUS critetla of optimal stant ex-
pansion only received ASA 2100 mg, while those not also received systemic
anticoegulation, Resu/ts:
Event In-hospital Discharge-6 month
Total Ranking Total Ranking
Death o 0 1 (0.60A) 1
Q-AMI 1 (0.60A) 1 1 (0.6%) 1
non-QAMI 6 (3.6%.) 6 0 0
CASG 1 (0.6”/0) o 2 (1.2%) 2
rePTCA 2 (1.2”/0) o *9 (6%)-(4°/0) 7
SAT 2 (1.2%) o 1 (0.6%) o
(“ including2ptewith repeat PTCA or another lesion)
QCA data are available in 131 pts: The MLD pre/post and at FU wea:
1.13, 2.91 and 2.17 mm, respectively. The incidence of restenosis was only
7%.
Cone/usions:ASA suffices in ceae of optimal stent expansion. in compar-
ison with historical series IVUS guidance substantially further reduces the
restenosis rate and need for subsequent PTCA.
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m CoronafYStentThromboai.:~anagementand
Long-termFollow-upResuit
H. Yokoi, H. Nosaka, T. Kimura, T. Tamura, Y. Nakegawa, N. Hameaaki,
M. Nobuyoshi. Kokura Memoria/ Hospita/, Kitakyushu, Japan
Despite the well-recognized incidence of stentthromboais, management and
late outcome of stent thrombosis have not been thoroughly defined. To eval-
uate the responsiveness to the proposed therapy and long-term follow-up
result, we reviewad 2649 coronaty stentings performed between June 1990
and June 1996. During the study period, stent thrombosis occurred in 46
patients (pts) (46 lesions) (1.7%) including 31 lesions (Ies) received Palmez-
Schatz (1.7%), 6 Ies Gianturco-Roubin (2.0%), 5 Ies Strecker (9.3%), 3 Ies
Cordis (2.0%),2 Ies ACS (2.5%) and 1 Ies AVE stent (1.4%). Repeat balloon
angioplasty (BA) was performed in 45 Ies (94%), 10 of whom were treated by
additional stent implantations because of poor responsiveness to BA. Eigh-
teen pts (40%) received thrombolysis and 15 pts (33%) treated by intre-aortic
balloon pumping. Although successful recanalization of the artery, defined as
<50% residual stenosis with TIMI 3 flow, was achieved in all Ies, refractoy
stent thrombosis occurred in 5 Ies (11%). Seven pts (15%) died and 7 pts
(15%) required bypase surgery during same hospitalization. Stent thromix-
sis resulted in Q-wave Ml occurred in 14 pts (30%) and composite major
mmplicetions occurred in 24 pts (54Yo). FU quantitative angiography was
obtained from 25 pts after 6 months or earlier when indicated by symptoms.
Bina~ restenosis, defined as >50% DS at FU, occurred in 5 pta (19%).
Target lesion revascularization (TLR) was performed in 3 pts (12%). Clinical
FU data was obtained after 12 months. The rates of survival free of Ml and
bypass surgery were 64% at 1 year. Conclusion: 1)Despite the emergent
mechanical recenalization, stent thrombosis wee associated with significant
adverse clinical outcomas. 2) Long-term outcome waa similar to the historical
group of non-atent thrombosis pts.
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El7291 StentReconstructionof Occluded/Obstructediiiofemo’mlVeinsandinferiorVenaCavato
Re-estebiiehAccessfor FutureCardiac
CatheterizationandCardiacSurgery
F.F.Ing, T.E. Fagan, R.G. Grifka, M.R. Nihill, K.M. Shaffar, C.E. Mullins.
TexasChildren’s Hospital, Bay/or Co/lega of Medicine, Houston, TX, USA
Patientawith congenital heart disease who undergo repeated cardiac catheter-
izations and/or have had indwelling ‘femoral venous lines following cardiac
surgety may develop occiusione/obstructions of their iliofemoral veins (IFV)
and inferior vena cava (IVC). Patients in whom further surgay or catheter-
izations are anticipated, inability to access the heart from the IFV may be
problematic. Methods: 10 pts, madian age 6.5 yra (range 0.5-11.4 yre), un-
